A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act ...

On April 29, 2025, a pharmaceutical company filed the latest constitutional challenge to the qui tam provision of the False Claims Act (“FCA”) when ...

Legal departments in the industry are facing "growing pressure from executive leadership and stakeholders who view IP ...

Ian L. Barlow and Duane C. Pozza of Wiley discuss regulatory, legal and self-regulatory action seeking to ensure that ...

A truck arrives to the loading bays at the US company Pfizer manufacturing plant in Puurs, Belgium.

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...